Stockreport

Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination with GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases [Yahoo! Finance]

Coya Therapeutics, Inc.  (COYA) 
PDF Company will seek to advance asset in neurodegenerative and autoimmune diseases through the next stages alongside a strategic partner HOUSTON, January 21, 2025 BUSINE [Read more]